No Detail Found!

Identification of anticancer potential of phytoconstituents of cuminum cyminum effective against hepatocellular carcinoma using computational approaches

Author(s)
Hina Majid Khan Department of Bioinformatics and Biosciences Faculty of Health and Life Sciences Capital University of Science and Technology (CUST), Islamabad, Pakistan
Bushra Bibi Department of Bioinformatics and Biosciences Faculty of Health and Life Sciences Capital University of Science and Technology (CUST), Islamabad, Pakistan
Erum Dilshad Department of Bioinformatics and Biosciences Faculty of Health and Life Sciences Capital University of Science and Technology (CUST), Islamabad, Pakistan
Rehana Rani Department of Life Sciences, Abasyn University, Islamabad, Pakistan
Abstract
Objective: To explore anticancer agents from Cuminum cyminum against hepatocellular carcinoma. Study Design: In-silico approaches using computational tools to determine the anticancer potential of phytoconstituents of cumin against hepatocellular carcinoma. Place and Duration of Study: This study was conducted from May 2021 to January 2022 at the Department of Bioinformatics and Biosciences of Capital University of Science and Technology, Islamabad, Pakistan. Materials and Methods: In this study, bioactive compounds of Cuminum cyminum representatives of Flavonoids, Phenolic acids, Terpenes, and Glycosides were selected to determine the anticancer potential of these ligands using an in-silico approach. Virtual screening of these ligands was carried out against the drug target, which was Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2). To identify novel anticancer bioactive compounds of Cuminum cyminum as potential inhibitors of VEGFR-2, Lipinski rule of five, Pharmacokinetic properties, and molecular docking were performed. Lipinski's rule of five and the Pharmacokinetic properties of ligands were studied through the pkCSM tool. Auto-dock performed molecular docking. Results: From these selected compounds, four ligands showed themselves as hit compounds. Among them, Quercetin was selected as the lead compound in this research against VEGFR-2 because it showed a -10.14 kcal/mol binding score and showed more active results with less toxic effects than the standard drug, which was Lenvatinib. All ligands-protein interaction visualization analyses were performed by PyMol molecular visualization tool and Discovery tool. Conclusion: Quercetin was identified as a lead compound that should be explored as a drug candidate in wet lab analysis to validate its efficacy for the treatment of HCC.
Publication Details
Page(s) 263-276
Published Journal: Life and Science, Volume: 4, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Cuminum cyminum, Hepatocellular carcinoma, molecular docking, Drug discovery, VEGFR-2
0

Citations

0

Downloads

38

Views